91 related articles for article (PubMed ID: 11225386)
1. [Diagnosis and staging of pancreatic carcinomas].
Böhmig M; Wiedenmann B; Rosewicz S
Dtsch Med Wochenschr; 2001 Feb; 126(5):113-6. PubMed ID: 11225386
[No Abstract] [Full Text] [Related]
2. [Tumor markers].
Schmiegel WH
Verh Dtsch Ges Inn Med; 1988; 94():77-9. PubMed ID: 3206938
[No Abstract] [Full Text] [Related]
3. [The status of early detection of pancreatic cancer].
Klapdor R
Internist (Berl); 1989 Nov; 30(11):752-8. PubMed ID: 2691436
[No Abstract] [Full Text] [Related]
4. [Early detection of pancreatic cancer].
Ishida T; Nakaizumi A; Tanaka S; Tatsuta M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():155-9. PubMed ID: 16457240
[No Abstract] [Full Text] [Related]
5. Early diagnosis of pancreatic cancer.
Furukawa H; Okada S; Kakizoe T
Hepatogastroenterology; 1999; 46(25):4-7. PubMed ID: 10228757
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of pancreatic cancer].
Uehara H; Iishi H; Tatsuta M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():101-6. PubMed ID: 16457229
[No Abstract] [Full Text] [Related]
7. Identification of early-stage pancreatic cancer biomarkers.
Expert Rev Mol Diagn; 2008 Nov; 8(6):675. PubMed ID: 18999919
[No Abstract] [Full Text] [Related]
8. [Pancreatic carcinoma: diagnosis].
Scheurer U
Ther Umsch; 1996 May; 53(5):377-86. PubMed ID: 8685856
[TBL] [Abstract][Full Text] [Related]
9. The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma.
Safi F; Roscher R; Beger HG
Bull Cancer; 1990; 77(1):83-91. PubMed ID: 2180502
[TBL] [Abstract][Full Text] [Related]
10. Tumor markers in pancreatic cancer--current concepts.
Schmiegel W
Hepatogastroenterology; 1989 Dec; 36(6):446-9. PubMed ID: 2693300
[TBL] [Abstract][Full Text] [Related]
11. [Urine diacetylspermine as a novel tumor marker for pancreatobiliary carcinomas].
Yamaguchi K; Nagano M; Torada N; Hamasaki N; Kawakita M; Tanaka M
Rinsho Byori; 2004 Apr; 52(4):336-9. PubMed ID: 15164602
[TBL] [Abstract][Full Text] [Related]
12. Individualizing therapy for pancreatic cancer.
Colvin EK; Chang DK; Merrett ND; Kench JG; Biankin AV
J Gastroenterol Hepatol; 2008 Dec; 23(12):1779-82. PubMed ID: 19120869
[No Abstract] [Full Text] [Related]
13. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
Jiang XT; Tao HQ; Zou SC
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690
[TBL] [Abstract][Full Text] [Related]
14. [Pancreatic cancer and tumor markers].
Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
Rinsho Byori; 1991 Jun; Suppl 89():58-72. PubMed ID: 1680205
[No Abstract] [Full Text] [Related]
15. [Tumor markers in the diagnosis of pancreatic carcinoma].
Lemma F; Bombardieri T; Salibra M; Trovato P; De Pasquale MC; Faraone V; Punturiero R; Di Mauro S
Minerva Med; 1989 Jul; 80(7):645-9. PubMed ID: 2779818
[No Abstract] [Full Text] [Related]
16. Diagnostic and therapeutic approach to pancreatic cancer.
Barkin JS; Goldstein JA
Biomed Pharmacother; 2000 Aug; 54(7):400-9. PubMed ID: 10989980
[TBL] [Abstract][Full Text] [Related]
17. [Controversies in timing of preoperative staging of pancreatic carcinomas].
Covarelli P; Cirocchi R; Rossi P; Mazieri M; Lolli G; Bisacci R; Fabbri C
G Chir; 1997; 18(1-2):65-8. PubMed ID: 9206486
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of pancreatic cancer].
Ariyama J
Gan No Rinsho; 1989 Jan; Spec No():323-8. PubMed ID: 2644473
[No Abstract] [Full Text] [Related]
19. Histological and molecular markers for pancreatic adenocarcinoma: can they help us define which patients should receive it?
Weber SM
Ann Surg Oncol; 2005 Mar; 12(3):200-1. PubMed ID: 15827809
[No Abstract] [Full Text] [Related]
20. Controversies in periampullary tumors.
Hamaloglu E; Yildiz BD; Karakoc D
Hepatogastroenterology; 2009; 56(89):54-8. PubMed ID: 19453028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
